what drugs are glp 1 agonists America's Poison Centers How GLP-1 medications are transforming
Description
Currently, no pharmacotherapies are available for the treatment of NAFLD/NASH and the disease is managed by targeting lifestyle changes and treating cardiometabolic risk factors [61]
This was due to the fact that they ushered in a new era in obesity, helping to reshape attitudes to the condition and how it is treated
10.1038/nrgastro.2016.107 [DOI] [PMC free article] [PubMed] [Google Scholar] Rebosio C., Balbi M., Passalacqua M., Ricciarelli R., Fedele E
I = 65%)
The researchers emphasized the need for larger, longer-term trials
